INTU vs MDGL · P/E 64, rev $18.83B vs rev $675.6M
Intuit Inc (INTU) versus Madrigal Pharmaceuticals Inc (MDGL) — a side-by-side from cached financials, not a winner call.
Intuit Inc (INTU) is a software - application company listed on US.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Latest reported INTU revenue for 2025-07-31 was $18.83B. Net income was $3.87B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
Latest reported MDGL revenue for 2026-06-30 was $675.6M. Net income was -$152.3M. MDGL currently screens at market cap $11.56B.
INTU currently screens at market cap $217.76B and trailing P/E 63.7. MDGL currently screens at market cap $11.56B.
Not investment advice. Open the INTU and MDGL stock pages for the full models.
Not investment advice.